StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.78+0.01 (+1.18%)

Close on Nov 17, 2026Market cap $9.26MP/E –Yield –

CytoMed Therapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -0.34 SGD. The highest annual figure on record is -0.22 SGD in fiscal 2024.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-0.34 SGD–
FY2024Dec 31, 2024-0.22 SGD–
FY2023Dec 31, 2023-0.39 SGD–
FY2022Dec 31, 2022-0.40 SGD–
FY2021Dec 31, 2021-0.30 SGD–
FY2020Dec 31, 2020-0.33 SGD–

More CytoMed Therapeutics figures

See a number that looks wrong?